Annual CFF
$31.65 M
+$26.73 M+544.13%
31 December 2023
Summary:
Sana Biotechnology annual cash flow from financing activities is currently $31.65 million, with the most recent change of +$26.73 million (+544.13%) on 31 December 2023. During the last 3 years, it has fallen by -$404.04 million (-92.74%). SANA annual CFF is now -94.99% below its all-time high of $631.75 million, reached on 31 December 2021.SANA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$2.08 M
-$8.54 M-80.41%
30 September 2024
Summary:
Sana Biotechnology quarterly cash flow from financing activities is currently $2.08 million, with the most recent change of -$8.54 million (-80.41%) on 30 September 2024. Over the past year, it has increased by +$1.90 million (+1013.37%). SANA quarterly CFF is now -99.67% below its all-time high of $626.70 million, reached on 31 March 2021.SANA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$200.82 M
+$1.90 M+0.95%
30 September 2024
Summary:
Sana Biotechnology TTM cash flow from financing activities is currently $200.82 million, with the most recent change of +$1.90 million (+0.95%) on 30 September 2024. Over the past year, it has increased by +$169.84 million (+548.05%). SANA TTM CFF is now -81.10% below its all-time high of $1.06 billion, reached on 31 March 2021.SANA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SANA Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +544.1% | +1013.4% | +548.0% |
| 3 y3 years | -92.7% | +30.4% | -68.1% |
| 5 y5 years | - | - | - |
SANA Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -95.0% | +544.1% | -98.9% | +1013.4% | -68.2% | +4365.7% |
| 5 y | 5 years | -95.0% | +544.1% | -99.7% | >+9999.0% | -81.1% | >+9999.0% |
| alltime | all time | -95.0% | +544.1% | -99.7% | >+9999.0% | -81.1% | >+9999.0% |
Sana Biotechnology Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.08 M(-80.4%) | $200.82 M(+1.0%) |
| June 2024 | - | $10.63 M(-94.3%) | $198.93 M(-8.7%) |
| Mar 2024 | - | $186.40 M(>+9900.0%) | $217.81 M(+588.3%) |
| Dec 2023 | $31.65 M(+544.1%) | $1.72 M(+818.7%) | $31.65 M(+2.1%) |
| Sept 2023 | - | $187.00 K(-99.4%) | $30.99 M(-4.4%) |
| June 2023 | - | $29.50 M(>+9900.0%) | $32.42 M(+621.0%) |
| Mar 2023 | - | $236.00 K(-77.8%) | $4.50 M(-8.5%) |
| Dec 2022 | $4.91 M | $1.06 M(-34.5%) | $4.91 M(-29.5%) |
| Sept 2022 | - | $1.62 M(+2.7%) | $6.97 M(+0.4%) |
| June 2022 | - | $1.58 M(+142.2%) | $6.95 M(+21.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $652.00 K(-79.1%) | $5.70 M(-99.1%) |
| Dec 2021 | $631.75 M(+45.0%) | $3.12 M(+95.4%) | $631.75 M(+0.5%) |
| Sept 2021 | - | $1.60 M(+379.3%) | $628.74 M(+0.3%) |
| June 2021 | - | $333.00 K(-99.9%) | $627.14 M(-41.0%) |
| Mar 2021 | - | $626.70 M(>+9900.0%) | $1.06 B(+143.8%) |
| Dec 2020 | $435.69 M(+94.7%) | $103.00 K(+2475.0%) | $435.69 M(+0.0%) |
| Sept 2020 | - | $4000.00(-100.0%) | $435.58 M(+0.0%) |
| June 2020 | - | $435.58 M(>+9900.0%) | $435.58 M(>+9900.0%) |
| Mar 2020 | - | $2000.00 | $2000.00 |
| Dec 2019 | $223.74 M | - | - |
FAQ
- What is Sana Biotechnology annual cash flow from financing activities?
- What is the all time high annual CFF for Sana Biotechnology?
- What is Sana Biotechnology annual CFF year-on-year change?
- What is Sana Biotechnology quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Sana Biotechnology?
- What is Sana Biotechnology quarterly CFF year-on-year change?
- What is Sana Biotechnology TTM cash flow from financing activities?
- What is the all time high TTM CFF for Sana Biotechnology?
- What is Sana Biotechnology TTM CFF year-on-year change?
What is Sana Biotechnology annual cash flow from financing activities?
The current annual CFF of SANA is $31.65 M
What is the all time high annual CFF for Sana Biotechnology?
Sana Biotechnology all-time high annual cash flow from financing activities is $631.75 M
What is Sana Biotechnology annual CFF year-on-year change?
Over the past year, SANA annual cash flow from financing activities has changed by +$26.73 M (+544.13%)
What is Sana Biotechnology quarterly cash flow from financing activities?
The current quarterly CFF of SANA is $2.08 M
What is the all time high quarterly CFF for Sana Biotechnology?
Sana Biotechnology all-time high quarterly cash flow from financing activities is $626.70 M
What is Sana Biotechnology quarterly CFF year-on-year change?
Over the past year, SANA quarterly cash flow from financing activities has changed by +$1.90 M (+1013.37%)
What is Sana Biotechnology TTM cash flow from financing activities?
The current TTM CFF of SANA is $200.82 M
What is the all time high TTM CFF for Sana Biotechnology?
Sana Biotechnology all-time high TTM cash flow from financing activities is $1.06 B
What is Sana Biotechnology TTM CFF year-on-year change?
Over the past year, SANA TTM cash flow from financing activities has changed by +$169.84 M (+548.05%)